Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
111 Inc (YI US)
Watchlist
124
Analysis
Information Technology
•
China
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Origin Energy
•
05 Dec 2022 00:30
Merger Arb Mondays (05 Dec) - Origin Energy, OZ Minerals, Genex, Bigtincan, Pendal, Golden Energy
This week, the highest gross spreads are VNET (65.0%), Alliance Aviation (55.7%), Genex (47.1%), Golden Energy (31.5%), 111 (27.1%), Origin Energy...
Arun George
Follow
1.8k Views
Share
bullish
•
Jinke Smart Services
•
31 Oct 2022 00:10
Merger Arb Mondays (31 Oct) - Jinke, Fengxiang, Lifestyle, Kingston, Pushpay, Nitro, Elmo, DTAC/True
This week, the highest gross spreads are VNET (84.7%), Alliance Aviation (48.4%), 111 (40.2%), Genex (25.0%), O2Micro (19.3%), Fengxiang (14.6%),...
Arun George
Follow
529 Views
Share
bullish
•
111 Inc
•
13 Sep 2022 15:41
111 Inc's Low-Balled Homecoming Is A Done Deal
Trading at a 9.3% gross spread to terms. That's okay for an illiquid arb. One that is neither firm, nor optically reasonable. The downside is...
David Blennerhassett
Follow
489 Views
Share
bullish
•
111 Inc
•
11 Sep 2022 14:59
111’s Opportunistic US$3.66 Bid from the Co-Founders
The offer price is unattractive, but this is a done deal as the co-founders control 92.0% of the voting power. At the last close, the annualised...
Arun George
Follow
701 Views
Share
bullish
•
Medlive Technology
•
14 Jul 2021 20:31
Medlive Technology IPO: Trading Debut
Medlive will commence trading on 15 July. Medlive priced at HK$27.20 and closed 10% up at HK$29.90 in the Futu grey market. Our DCF sensitivity...
Arun George
Follow
550 Views
Share
First
Previous
14
15
16
17
18
19
20
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x